Salute e Benessere
Notice of Extraordinary General Meeting in Enzymatica AB (publ)
Those who wish to participate in the annual general meeting must:
The notice shall include full name, personal identification number or corporate registration number, address and daytime telephone number and, where appropriate, information about representative, proxy and assistants. The number of assistants may not be more than two (2). The notification should, where appropriate, be accompanied by proxies, registration certificates and other documents of authority.
In order to be entitled to participate in the meeting, a shareholder whose shares are registered in the name of a nominee must, in addition to giving notice of participation in the extra general meeting, register its shares in its own name at Euroclear Sweden AB so that the shareholder is listed in the share register as of the record date of July 29, 2024 . Such registration may be temporary (so called voting rights registration), and a request for such voting rights registration shall be made to the nominee, in accordance with the nominee's routines, at such time in advance as decided by the nominee. Voting rights registration that has been made no later than July 31, 2024 , will be considered in the presentation of the share register.
If shareholders are to be represented by a proxy, the proxy must bring a written, dated and signed by the shareholder power of attorney to the meeting. The power of attorney must not be older than one (1) year, unless a longer period of validity (but at most five (5) years) has been specified in the power of attorney. If the power of attorney has been issued by a legal entity, the representative must also have a current registration certificate or equivalent authorization document for the legal entity. To facilitate entry, a copy of the power of attorney and other authorization documents should be attached to the notification to the general meeting. Proxy forms will be kept available on the Company's website, www.enzymatica.com, and at the Company's head office and will be sent by post to shareholders who contact the Company and state their address.
The Board of Directors proposes that attorney at law Markus Nivinger, Setterwalls Law Firm, shall be elected chairman of the meeting.
The Board of Directors proposes that the meeting approve the board's decision of
18 July 2024 that the Company's share capital should increase by a maximum of
SEK 2,774,117.32 through a new rights issue of a maximum of 69,352,888 shares, each with a quota value of
SEK 0.04 .
The following terms and conditions shall apply to the issue.
It was noted that documents in accordance with Chap 13 Sec 6 of the Companies Act had been presented in the proper order.
The Board of Directors, or the person appointed by the Board of Directors, shall have the right to make the minor adjustments to the above decision that may prove necessary in connection with registration of the decision at the Swedish Companies Registration Office or Euroclear Sweden AB.
Documents that must be provided before the meeting according to the Swedish Companies Act will be kept available at the Company and on the Company's website, www.enzymatica.com, at least two weeks before the day of the meeting and will be sent free of charge to shareholders who request it and provide their postal address. In other respects, the Board of Directors' complete resolution proposal appears in the notice.
The board and the managing director must, if a shareholder requests it and the board considers that it can happen without significant damage to the company, provide information about conditions that may affect the assessment of a matter on the agenda. The disclosure obligation also refers to the company's relationship with other group companies, the consolidated accounts and such relationships regarding subsidiaries as referred to in the previous sentence.
Shareholders who wish to submit questions in advance can do so by mail to Sriwarint Olsson with the address Enzymatica AB, Attn: "Extra general meeting 2024", Ideon Science Park, Scheelevägen 19, 223 70 Lund or by e-mail to sriwarint.olsson@enzymatica.com. Submitted questions should include the shareholder's name including the shareholder's social security number or corporate identity number. It is also recommended that submitted questions include the shareholder's mailing address, email address and telephone number.
The total number of shares and votes in the Company on the day of this notice amounts to 173,382,220. The Company does not own any own shares.
For information on how your personal data is processed, please refer to the privacy policy available at the webpage of Euroclear Sweden AB.
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.
_____________
Lund in
July 2024
Claus Egstrand, CEO, Enzymatica AB
Phone: +44 7780 22 8385 | Email: claus.egstrand@enzymatica.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/enzymatica-ab/r/notice-of-extraordinary-general-meeting-in-enzymatica-ab--publ-,c4016239
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/notice-of-extraordinary-general-meeting-in-enzymatica-ab-publ-302200365.html